drugset / Trial / NCT01620554
Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)
RandomizedParallel-groupDouble-blindTreatment
Summary
Prospective, multicenter, double-blind, phase II, randomized, dose-response study in 5 parallel groups (dose-range).
Timeline
- Start
- 2010-10
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pitolisant | Small molecule | 5 mg | Oral |
| Subject | Pitolisant | Small molecule | 10 mg | Oral |
| Subject | Pitolisant | Small molecule | 20 mg | Oral |
| Subject | Pitolisant | Small molecule | 40 mg | Oral |